As such, antibodies against catecholamine receptors able to modulate heart frequency were identified, along with auto-antibodies against angiotensin 2 receptor and endothelin in patients with POTS (Figure 3) [81]. The gene discussed is ADRB2; the disease is postural orthostatic tachycardia syndrome.